Ventricular fibrillation: triggers, mechanisms and therapies.

Ventricular fibrillation (VF) is a common, life-threatening arrhythmia responsible for significant morbidity and mortality. Due to challenges in safely mapping VF, a comprehensive understanding of its mechanisms remains elusive. Recent findings have provided new insights into mechanisms that sustain early VF. Notably, the central role of electrical rotors and catheter-based ablation of VF rotor substrate have been recently reported. In this article, we will review data regarding four stages of VF: initiation, transition, maintenance and evolution. We will discuss the particular mechanisms for each stage and therapies targeting these mechanisms. We also examine inherited arrhythmia syndromes, including the mechanisms and therapies specific to each. We hope that the overview of VF outlined in this work will assist other investigators in designing future therapies to interrupt this life-threatening arrhythmia.

[1]  J. Olgin,et al.  Effects of Thoracic Spinal Cord Stimulation on Cardiac Autonomic Regulation of the Sinus and Atrioventricular Nodes , 2002, Journal of cardiovascular electrophysiology.

[2]  S. Narayan,et al.  A case of a human ventricular fibrillation rotor localized to ablation sites for scar-mediated monomorphic ventricular tachycardia. , 2013, Heart rhythm.

[3]  R. von Känel,et al.  Chronic posttraumatic stress and its predictors in patients living with an implantable cardioverter defibrillator. , 2011, Journal of affective disorders.

[4]  O. Berenfeld,et al.  Molecular mechanisms and global dynamics of fibrillation: an integrative approach to the underlying basis of vortex-like reentry. , 2004, Journal of theoretical biology.

[5]  Karl Swedberg,et al.  Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. , 2003, The New England journal of medicine.

[6]  D. Zipes,et al.  Thoracic Spinal Cord Stimulation Reduces the Risk of Ischemic Ventricular Arrhythmias in a Postinfarction Heart Failure Canine Model , 2005, Circulation.

[7]  Jichao Zhao,et al.  Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts. , 2015, European heart journal.

[8]  J Jalife,et al.  Purkinje-muscle reentry as a mechanism of polymorphic ventricular arrhythmias in a 3-dimensional model of the ventricles. , 1998, Circulation research.

[9]  R. Kloner,et al.  Improved Left Ventricular Function and Reduced Necrosis after Myocardial Ischemia/Reperfusion in Rabbits Treated with Ranolazine, an Inhibitor of the Late Sodium Channel , 2006, Journal of Pharmacology and Experimental Therapeutics.

[10]  N. Freemantle,et al.  Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses. , 2011, Journal of the American College of Cardiology.

[11]  Kumaraswamy Nanthakumar,et al.  Intramural Activation During Early Human Ventricular Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.

[12]  Frank Bogun,et al.  Relationship between burden of premature ventricular complexes and left ventricular function. , 2010, Heart rhythm.

[13]  S. Narayan,et al.  Percutaneous Stellate Ganglion Block Suppressing VT and VF in a Patient Refractory to VT Ablation , 2013, Journal of cardiovascular electrophysiology.

[14]  J F Leclercq,et al.  Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. , 1989, American heart journal.

[15]  M. Vargas,et al.  Effects of in-hospital low targeted temperature after out of hospital cardiac arrest: A systematic review with meta-analysis of randomized clinical trials. , 2015, Resuscitation.

[16]  Richard H Clayton,et al.  Human Ventricular Fibrillation During Global Ischemia and Reperfusion: Paradoxical Changes in Activation Rate and Wavefront Complexity , 2011, Circulation. Arrhythmia and electrophysiology.

[17]  Mehra,et al.  A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. , 1990, Circulation.

[18]  José Jalife,et al.  Rotors and the Dynamics of Cardiac Fibrillation , 2013, Circulation research.

[19]  M. Kayıkçıoğlu,et al.  Tachycardia‐Induced Cardiomyopathy in Patients With Idiopathic Ventricular Arrhythmias: The Incidence, Clinical and Electrophysiologic Characteristics, and the Predictors , 2011, Journal of cardiovascular electrophysiology.

[20]  O. Berenfeld,et al.  Shaping of a scroll wave filament by cardiac fibers. , 2001, Physical review. E, Statistical, nonlinear, and soft matter physics.

[21]  Tae Yun Kim,et al.  Spatially Discordant Alternans and Arrhythmias in Tachypacing-Induced Cardiac Myopathy in Transgenic LQT1 Rabbits: The Importance of IKs and Ca2+ Cycling , 2015, PloS one.

[22]  Michel Haïssaguerre,et al.  Mapping and Ablation of Idiopathic Ventricular Fibrillation , 2002, Frontiers in cardiovascular medicine.

[23]  Thomas Lavergne,et al.  Sudden cardiac arrest associated with early repolarization. , 2008, The New England journal of medicine.

[24]  R. A. Gray,et al.  Mechanisms of Cardiac Fibrillation , 1995, Science.

[25]  D. Rosenbaum,et al.  Connexin Gene Transfer Preserves Conduction Velocity and Prevents Atrial Fibrillation , 2012, Circulation.

[26]  J. Nolasco,et al.  A graphic method for the study of alternation in cardiac action potentials. , 1968, Journal of applied physiology.

[27]  J. K. Donahue,et al.  Gene therapy approaches to ventricular tachyarrhythmias. , 2007, Journal of electrocardiology.

[28]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[29]  O. Berenfeld,et al.  Dynamics of intramural scroll waves in three-dimensional continuous myocardium with rotational anisotropy. , 1999, Journal of theoretical biology.

[30]  Yi Zheng,et al.  Ventricular fibrillation mechanisms and cardiac restitutions: An investigation by simulation study on whole-heart model , 2015, Comput. Biol. Medicine.

[31]  W. Rheinboldt,et al.  A COMPUTER MODEL OF ATRIAL FIBRILLATION. , 1964, American heart journal.

[32]  Juan Cinca,et al.  Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. , 2009, Journal of the American College of Cardiology.

[33]  C. Callaway,et al.  Regional variation in out-of-hospital cardiac arrest incidence and outcome. , 2008, JAMA.

[34]  S. Priori,et al.  Left Cardiac Sympathetic Denervation in the Management of High-Risk Patients Affected by the Long-QT Syndrome , 2004, Circulation.

[35]  J. Mcanulty,et al.  Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. , 1996, The American journal of cardiology.

[36]  Bruce B. Lerman,et al.  Reversal of Cardiomyopathy in Patients With Repetitive Monomorphic Ventricular Ectopy Originating From the Right Ventricular Outflow Tract , 2005, Circulation.

[37]  M. Franz The Electrical Restitution Curve Revisited: , 2003, Journal of cardiovascular electrophysiology.

[38]  G. Breithardt,et al.  Efficacy of Antiarrhythmic Drugs in Patients With Arrhythmogenic Right Ventricular Disease: Results in Patients With Inducible and Noninducible Ventricular Tachycardia , 1992, Circulation.

[39]  R. Prescott,et al.  CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION , 1982, The Lancet.

[40]  R. Hauer,et al.  Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol. , 2012, Journal of the American College of Cardiology.

[41]  M. Pfeffer,et al.  Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. , 1999, Journal of the American College of Cardiology.

[42]  Robert G. Weiss,et al.  Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy , 2005, Circulation.

[43]  R. Gray,et al.  Spatial and temporal organization during cardiac fibrillation , 1998, Nature.

[44]  Kenneth Egstrup,et al.  Effect of dofetilide in patients with recent myocardial infarction and left-ventricular dysfunction: a randomised trial , 2000, The Lancet.

[45]  S. Steen,et al.  Continuous intratracheal insufflation of oxygen improves the efficacy of mechanical chest compression-active decompression CPR. , 2004, Resuscitation.

[46]  B. Desjardins,et al.  Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction. , 2009, Heart rhythm.

[47]  H. Calkins,et al.  Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. , 2006, Heart rhythm.

[48]  M. Link,et al.  2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2012, Journal of the American College of Cardiology.

[49]  K. Anstrom,et al.  Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). , 2011, Heart rhythm.

[50]  A. Toso,et al.  Results of nonguided subtotal endocardiectomy associated with left ventricular reconstruction in patients with ischemic ventricular arrhythmias. , 1994, The Journal of thoracic and cardiovascular surgery.

[51]  E. McVeigh,et al.  Model of reentrant ventricular tachycardia based on infarct border zone geometry predicts reentrant circuit features as determined by activation mapping. , 2007, Heart rhythm.

[52]  Peng-Sheng Chen,et al.  Effects of Subendocardial Ablation on Anodal Supernormal Excitation and Ventricular Vulnerability in Open‐Chest Dogs , 1993, Circulation.

[53]  S. Russell,et al.  Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2012, Circulation. Arrhythmia and electrophysiology.

[54]  R. W. Joyner,et al.  Cellular mechanisms of delayed recovery of excitability in ventricular tissue. , 1991, The American journal of physiology.

[55]  Javier Moreno,et al.  Three distinct phases of VF during global ischemia in the isolated blood-perfused pig heart. , 2007, American journal of physiology. Heart and circulatory physiology.

[56]  B Lown,et al.  Predictors of antiarrhythmic drug efficacy in patients with malignant ventricular tachyarrhythmias. , 1987, American heart journal.

[57]  Wouter-Jan Rappel,et al.  Rotor stability separates sustained ventricular fibrillation from self-terminating episodes in humans. , 2014, Journal of the American College of Cardiology.

[58]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[59]  F. Marchlinski,et al.  Symptoms and electrocardiographically documented rhythm preceding spontaneous shocks in patients with implantable cardioverter-defibrillator. , 1993, The American journal of cardiology.

[60]  Elliot B. Bourgeois,et al.  Panoramic optical mapping shows wavebreak at a consistent anatomical site at the onset of ventricular fibrillation. , 2012, Cardiovascular research.

[61]  S. S. Hull,et al.  Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. , 1991, Circulation research.

[62]  G. Gintant,et al.  Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells. , 1991, Circulation research.

[63]  G. Kay,et al.  Idiopathic Focal Ventricular Arrhythmias Originating from the Anterior Papillary Muscle in the Left Ventricle , 2009, Journal of cardiovascular electrophysiology.

[64]  S. Viskin,et al.  Effects of Electrophysiologic‐Guided Therapy with Class IA Antiarrhythmic Drugs on the Long‐Term Outcome of Patients with Idiopathic Ventricular Fibrillation with or without the Brugada Syndrome , 1999, Journal of cardiovascular electrophysiology.

[65]  P. Sutton,et al.  Effect of Adrenergic Stimulation on Action Potential Duration Restitution in Humans , 2003, Circulation.

[66]  Vincent Jacquemet,et al.  Automaticity in acute ischemia: bifurcation analysis of a human ventricular model. , 2011, Physical review. E, Statistical, nonlinear, and soft matter physics.

[67]  C. Tracy,et al.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.

[68]  N. Trayanova,et al.  Action potential dynamics explain arrhythmic vulnerability in human heart failure: a clinical and modeling study implicating abnormal calcium handling. , 2008, Journal of the American College of Cardiology.

[69]  S. Laniado,et al.  Response of recurrent sustained ventricular tachycardia to verapamil. , 1981, British heart journal.

[70]  Frank Bogun,et al.  Relationship of frequent postinfarction premature ventricular complexes to the reentry circuit of scar-related ventricular tachycardia. , 2008, Heart rhythm.

[71]  S. Pogwizd,et al.  The contribution of nonreentrant mechanisms to malignant ventricular arrhythmias. , 1992, Basic research in cardiology.

[72]  CIBIS-II Investigators and Committees The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[73]  Wouter-Jan Rappel,et al.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. , 2012, Journal of the American College of Cardiology.

[74]  S. Narayan,et al.  Long-term follow-up of idiopathic ventricular fibrillation ablation: a multicenter study. , 2009, Journal of the American College of Cardiology.

[75]  A Garfinkel,et al.  Electrophysiological heterogeneity and stability of reentry in simulated cardiac tissue. , 2001, American journal of physiology. Heart and circulatory physiology.

[76]  Henggui Zhang,et al.  The canine virtual ventricular wall: a platform for dissecting pharmacological effects on propagation and arrhythmogenesis. , 2008, Progress in biophysics and molecular biology.

[77]  Natalia A Trayanova,et al.  Mechanisms of Human Atrial Fibrillation Initiation: Clinical and Computational Studies of Repolarization Restitution and Activation Latency , 2012, Circulation. Arrhythmia and electrophysiology.

[78]  Ruben Coronel,et al.  Intrinsic heterogeneity in repolarization is increased in isolated failing rabbit cardiomyocytes during simulated ischemia. , 2003, Cardiovascular research.

[79]  Robert F Gilmour,et al.  Ionic mechanism of electrical alternans. , 2002, American journal of physiology. Heart and circulatory physiology.

[80]  B Lown,et al.  Monitoring for Serious Arrhythmias and High Risk of Sudden Death , 1975, Circulation.

[81]  Hui-Nam Pak,et al.  Catheter Ablation of Ventricular Fibrillation in Rabbit Ventricles Treated With &bgr;-Blockers , 2003 .

[82]  D. Lin,et al.  Catheter ablation of ventricular fibrillation: importance of left ventricular outflow tract and papillary muscle triggers. , 2014, Heart rhythm.

[83]  A. L. Wit,et al.  Spontaneous and Induced Cardiac Arrhythmias in Subendocardial Purkinje Fibers Surviving Extensive Myocardial Infarction in Dogs , 1973, Circulation research.

[84]  Eric Fain,et al.  Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. , 2004, The New England journal of medicine.

[85]  A. Castellanos,et al.  Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. , 1998, Circulation.

[86]  A. Mahajan,et al.  Cardiac sympathetic denervation in patients with refractory ventricular arrhythmias or electrical storm: intermediate and long-term follow-up. , 2014, Heart rhythm.

[87]  Sanjiv M Narayan,et al.  T-wave alternans, restitution of human action potential duration, and outcome. , 2007, Journal of the American College of Cardiology.

[88]  Kumaraswamy Nanthakumar,et al.  Ventricular fibrillation in myopathic human hearts: mechanistic insights from in vivo global endocardial and epicardial mapping. , 2007, American journal of physiology. Heart and circulatory physiology.

[89]  F. Gaita,et al.  Can spinal cord stimulation reduce ventricular arrhythmias? , 2012, Heart rhythm.

[90]  W. Baxter,et al.  Stationary and drifting spiral waves of excitation in isolated cardiac muscle , 1992, Nature.

[91]  Wouter-Jan Rappel,et al.  Theoretical considerations for mapping activation in human cardiac fibrillation. , 2013, Chaos.

[92]  F. Ohsuzu,et al.  Altered action potential dynamics in electrically remodeled canine atria: evidence for altered intracellular Ca2+ handling. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[93]  Alan Garfinkel,et al.  Action potential duration restitution and ventricular fibrillation due to rapid focal excitation. , 2002, American journal of physiology. Heart and circulatory physiology.

[94]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[95]  R. Ideker,et al.  Activation becomes highly organized during long-duration ventricular fibrillation in canine hearts. , 2010, American journal of physiology. Heart and circulatory physiology.

[96]  Po-Cheng Chang,et al.  Epicardial ablation of rotors suppresses inducibility of acetylcholine-induced atrial fibrillation in left pulmonary vein-left atrium preparations in a beagle heart failure model. , 2011, Journal of the American College of Cardiology.

[97]  A. Garfinkel,et al.  Chaos and the transition to ventricular fibrillation: a new approach to antiarrhythmic drug evaluation. , 1999, Circulation.

[98]  Karen L. Gunson,et al.  Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. , 2006, Journal of the American College of Cardiology.

[99]  W. Rappel,et al.  Modifying Ventricular Fibrillation by Targeted Rotor Substrate Ablation: Proof‐of‐Concept from Experimental Studies to Clinical VF , 2015, Journal of cardiovascular electrophysiology.

[100]  David J. Christini,et al.  Effect of β-adrenergic blockade on dynamic electrical restitution in vivo , 2004 .

[101]  R. Ideker,et al.  The effect of chemical ablation of the endocardium on ventricular fibrillation threshold. , 1986, Circulation.

[102]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[103]  M. Volpe,et al.  Osteopontin and Galectin‐3 Predict the Risk of Ventricular Tachycardia and Fibrillation in Heart Failure Patients with Implantable Defibrillators , 2014, Journal of cardiovascular electrophysiology.

[104]  A. Camm,et al.  Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[105]  B. Wilkoff,et al.  Differences in effects of electrical therapy type for ventricular arrhythmias on mortality in implantable cardioverter-defibrillator patients. , 2010, Heart rhythm.

[106]  J. Ruskin,et al.  Electrical alternans and vulnerability to ventricular arrhythmias. , 1994, The New England journal of medicine.

[107]  J. Coote,et al.  Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. , 2007, Cardiovascular research.

[108]  C Antzelevitch,et al.  Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome. , 1998, Circulation.

[109]  Hani N. Sabbah,et al.  Vagus nerve stimulation in experimental heart failure , 2011, Heart Failure Reviews.

[110]  Douglas K Owens,et al.  Cost-effectiveness of implantable cardioverter-defibrillators. , 2005, The New England journal of medicine.

[111]  R. Berger,et al.  Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[112]  H. Pak,et al.  Both Purkinje cells and left ventricular posteroseptal reentry contribute to the maintenance of ventricular fibrillation in open-chest dogs and swine: effects of catheter ablation and the ventricular cut-and-sew operation. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[113]  Vadim V Fedorov,et al.  A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails. , 2012, Journal of the American College of Cardiology.

[114]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[115]  Tachapong Ngarmukos,et al.  Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by Catheter Ablation Over the Anterior Right Ventricular Outflow Tract Epicardium , 2011, Circulation.

[116]  R. Clayton,et al.  Whole heart action potential duration restitution properties in cardiac patients: a combined clinical and modelling study , 2006, Experimental physiology.

[117]  A. Garfinkel,et al.  From Pulsus to Pulseless: The Saga of Cardiac Alternans , 2006, Circulation research.

[118]  M. Copass,et al.  Changing incidence of out-of-hospital ventricular fibrillation, 1980-2000. , 2002, JAMA.

[119]  Hui-Nam Pak,et al.  Spatial Dispersion of Action Potential Duration Restitution Kinetics Is Associated with Induction of Ventricular Tachycardia/Fibrillation in Humans , 2004, Journal of cardiovascular electrophysiology.

[120]  Arthur J Moss,et al.  Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. , 2013, European heart journal.

[121]  A Garfinkel,et al.  Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolated swine right ventricle. , 1999, Circulation.

[122]  L. Tavazzi,et al.  Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002 .

[123]  Mark A Hlatky,et al.  ACC/AHA/HRS 2008 guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: executive summary. , 2008, Heart rhythm.

[124]  Carl J. Wiggers,et al.  Studies of Ventricular Fibrillation Caused by Electric Shock: , 1930, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[125]  J. Weiss,et al.  Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine. , 2011, Journal of the American College of Cardiology.

[126]  Arthur L. Kellermann,et al.  Predictors of Survival From Out-of-Hospital Cardiac Arrest A Systematic Review and Meta-Analysis , 2013 .

[127]  S. Hohnloser,et al.  Elevated Heart Rate Triggers Action Potential Alternans and Sudden Death. Translational Study of a Homozygous KCNH2 Mutation , 2014, PloS one.

[128]  Maxime Sermesant,et al.  Cardiac arrythmias: multimodal assessment integrating body surface ECG mapping into cardiac imaging. , 2014, Radiology.

[129]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[130]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.